Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Read more about Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer.
Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization. Read more about Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.
Invasion of human follicular thyroid carcinoma cells in an in vivo invasion model. Read more about Invasion of human follicular thyroid carcinoma cells in an in vivo invasion model.
Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Read more about Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer.
Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter. Read more about Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
Thyroidectomy for the treatment of Graves' disease. Read more about Thyroidectomy for the treatment of Graves' disease.
Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature. Read more about Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature.
A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis. Read more about A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.
Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin. Read more about Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin.